Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma.

Abstract:

:Interleukin-15 (IL-15) induces proliferation and promotes cell survival of human T and B lymphocytes, natural killer cells, and neutrophils. Here we report the constitutive expression of a functional IL-15 receptor (IL-15R) in 6 of 6 myeloma cell lines and in CD38(high)/CD45(low )plasma cells belonging to 14 of 14 patients with multiple myeloma. Furthermore, we detected IL-15 transcripts in all 6 myeloma cell lines, and IL-15 protein in 4/6 cell lines and also in the primary plasma cells of 8/14 multiple myeloma patients. Our observations confirm the existence of an autocrine IL-15 loop and point to the potential paracrine stimulation of myeloma cells by IL-15 released from the cellular microenvironment. Blocking autocrine IL-15 in cell lines increased the rate of spontaneous apoptosis, and the degree of this effect was comparable to the pro-apoptotic effect of depleting autocrine IL-6 by antibody targeting. IL-15 was also capable of substituting for autocrine IL-6 in order to promote cell survival and vice versa. In short-term cultures of primary myeloma cells, the addition of IL-15 reduced the percentage of tumor cells spontaneously undergoing apoptosis. Furthermore, IL-15 lowered the responsiveness to Fas-induced apoptosis and to cytotoxic treatment with vincristine and doxorubicin but not with dexamethasone. These data add IL-15 to the list of important factors promoting survival of multiple myeloma cells and demonstrate that it can be produced and be functionally active in an autocrine manner. (Blood. 2000;95:610-618)

journal_name

Blood

journal_title

Blood

authors

Tinhofer I,Marschitz I,Henn T,Egle A,Greil R

subject

Has Abstract

pub_date

2000-01-15 00:00:00

pages

610-8

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

95

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Activated protein C inhibits high mobility group box 1 signaling in endothelial cells.

    abstract::A pathogenic role for high-mobility group box 1 (HMGB1) protein has been postulated in severe sepsis. Activated protein C (APC) is the only drug approved by the Food and Drug Administration for severe sepsis; however, its effect on HMGB1 signaling has never been investigated. Here, we monitored the effect of APC on th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-360701

    authors: Bae JS,Rezaie AR

    更新日期:2011-10-06 00:00:00

  • Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells.

    abstract::Glucocorticoids are keystone drugs in the treatment of childhood acute lymphoblastic leukemia (ALL). To get more insight in signal transduction pathways involved in glucocorticoid-induced apoptosis, Affymetrix U133A GeneChips were used to identify transcriptionally regulated genes on 3 and 8 hours of prednisolone expo...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-11-056366

    authors: Tissing WJ,den Boer ML,Meijerink JP,Menezes RX,Swagemakers S,van der Spek PJ,Sallan SE,Armstrong SA,Pieters R

    更新日期:2007-05-01 00:00:00

  • Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes.

    abstract::Approximately 20% of childhood B-precursor acute lymphoblastic leukemia (ALL) has a TEL-AML1 fusion gene, often in association with deletions of the nonrearranged TEL allele. TEL-AML1 gene fusion appears to be an initiating event and usually occurs before birth, in utero. This subgroup of ALL generally presents with l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.558

    authors: Ford AM,Fasching K,Panzer-Grümayer ER,Koenig M,Haas OA,Greaves MF

    更新日期:2001-08-01 00:00:00

  • Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.

    abstract::Although sickle cell disease (SCD) has a variable clinical course, many patients develop end-organ complications that are associated with significant morbidity and early mortality. Myeloablative allogeneic HSCT (allo-HSCT) is curative but has been historically performed only in children younger than 16 years of age. M...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-01-332510

    authors: Hsieh MM,Fitzhugh CD,Tisdale JF

    更新日期:2011-08-04 00:00:00

  • Human CD34+ fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment.

    abstract::Hematopoietic stem cells differentiate in the thymus to T cells along precisely defined intermediates. This process is thymic epithelium dependent and involves cytokines and cell-cell interactions between thymic stroma and T-cell precursors. Here we report that highly purified human CD34++ fetal liver stem cells diffe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Plum J,De Smedt M,Defresne MP,Leclercq G,Vandekerckhove B

    更新日期:1994-09-01 00:00:00

  • Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin.

    abstract::Karyotypes in multiple myeloma (MM) are complex and exhibit numerous structural and numerical aberrations. The largest subset of structural chromosome anomalies in clinical specimens and cell lines involves aberrations of chromosome 1. Unbalanced translocations and duplications involving all or part of the whole long ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sawyer JR,Tricot G,Mattox S,Jagannath S,Barlogie B

    更新日期:1998-03-01 00:00:00

  • Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

    abstract::Treatment of human monocytes with vascular endothelial growth factor (VEGF) isolated from tumor cell supernatants was reported to induce monocyte activation and migration. In this study we show that recombinant human VEGF165, and VEGF121 had a maximal effect on human monocyte migration at 65 to 250 pmol/L. Chemotactic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Barleon B,Sozzani S,Zhou D,Weich HA,Mantovani A,Marmé D

    更新日期:1996-04-15 00:00:00

  • High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine.

    abstract::Although virtually all pediatric patients with acute myeloid leukemia (AML) achieve a complete remission after initial induction therapy, 30%-40% of patients will encounter a relapse and have a dismal prognosis. To prevent relapses, personalized treatment strategies are currently being developed, which target specific...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-03-276519

    authors: Bachas C,Schuurhuis GJ,Hollink IH,Kwidama ZJ,Goemans BF,Zwaan CM,van den Heuvel-Eibrink MM,de Bont ES,Reinhardt D,Creutzig U,de Haas V,Assaraf YG,Kaspers GJ,Cloos J

    更新日期:2010-10-14 00:00:00

  • Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

    abstract::Allogeneic hematopoietic stem cell transplantation (HSCT) is widely used to treat hematopoietic cell disorders but is often complicated by graft-versus-host disease (GVHD), which causes severe epithelial damage. Here we have investigated longitudinally the effects of induction chemotherapy, conditioning radiochemother...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2013-11-536888

    authors: Munneke JM,Björklund AT,Mjösberg JM,Garming-Legert K,Bernink JH,Blom B,Huisman C,van Oers MH,Spits H,Malmberg KJ,Hazenberg MD

    更新日期:2014-07-31 00:00:00

  • Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

    abstract::A series of alterations in the cellular genome affecting the expression or function of genes controlling cell growth and differentiation is considered to be the main cause of cancer. These mutational events include activation of oncogenes and inactivation of tumor suppressor genes. The elucidation of human cancer at t...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Reuter CW,Morgan MA,Bergmann L

    更新日期:2000-09-01 00:00:00

  • Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: an exploration study.

    abstract::Genetic risk factors contribute to adverse outcome of hematopoietic stem cell transplantation (HSCT). Mismatching of the HLA complex most strongly determines outcomes, whereas non-HLA genetic polymorphisms are also having an impact. Although the majority of HSCTs are mismatched, only few studies have investigated the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-406785

    authors: Harkensee C,Oka A,Onizuka M,Middleton PG,Inoko H,Hirayasu K,Kashiwase K,Yabe T,Nakaoka H,Gennery AR,Ando K,Morishima Y,Japan Marrow Donor Program.

    更新日期:2012-06-28 00:00:00

  • G-protein-gated inwardly rectifying potassium channels regulate ADP-induced cPLA2 activity in platelets through Src family kinases.

    abstract::ADP-induced TXA2 generation requires the costimulation of P2Y1, P2Y12, and the GPIIb/IIIa receptors. Signaling events downstream of the P2Y receptors that contribute to ADP-induced TXA2 generation have not been clearly delineated. In this study, we have investigated the role of G-protein-gated inwardly rectifying pota...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-03-010330

    authors: Shankar H,Kahner BN,Prabhakar J,Lakhani P,Kim S,Kunapuli SP

    更新日期:2006-11-01 00:00:00

  • Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.

    abstract::Myeloproliferative neoplasms (MPNs) are a group of clonal disorders characterized by aberrant hematopoietic proliferation and an increased tendency toward leukemic transformation. We used targeted next-generation sequencing (NGS) of 104 genes to detect somatic mutations in a cohort of 197 MPN patients and followed clo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-11-537167

    authors: Lundberg P,Karow A,Nienhold R,Looser R,Hao-Shen H,Nissen I,Girsberger S,Lehmann T,Passweg J,Stern M,Beisel C,Kralovics R,Skoda RC

    更新日期:2014-04-03 00:00:00

  • Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension.

    abstract::Pulmonary arterial hypertension (PAH) is a progressive disease characterized by lung endothelial dysfunction and vascular remodeling. Recently, bone marrow progenitor cells have been localized to PAH lungs, raising the question of their role in disease progression. Independently, serotonin (5-HT) and its receptors hav...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-358374

    authors: Launay JM,Hervé P,Callebert J,Mallat Z,Collet C,Doly S,Belmer A,Diaz SL,Hatia S,Côté F,Humbert M,Maroteaux L

    更新日期:2012-02-16 00:00:00

  • Activation of human granulocytes by arachidonic acid: its use and limitations for investigating granulocyte functions.

    abstract::The effects of arachidonic acid on human granulocytes (polymorphonuclear neutrophil leukocytes, PMN) were examined with respect to early events associated with activation of the superoxide (O2-)-generating system and its reactivation with other stimuli after the addition of fatty acid-free bovine serum albumin. As wit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cohen HJ,Chovaniec ME,Takahashi K,Whitin JC

    更新日期:1986-04-01 00:00:00

  • Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma.

    abstract::Bacterial DNA and synthetic oligodeoxynucleotides containing the CpG motif (CpG ODN) can activate various immune cell subsets, including natural killer cells and macrophages. We evaluated whether the combination of CpG ODN and antitumor monoclonal antibody is effective at preventing tumor growth in an immunocompetent ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wooldridge JE,Ballas Z,Krieg AM,Weiner GJ

    更新日期:1997-04-15 00:00:00

  • Intermediate syndrome of platelet dysfunction.

    abstract::We studied eight patients with intermittent bleeding episodes usually following trauma and associated with the ingestion of medicine known to interfere with platelet function. All patients had a normal or minimally prolonged baseline bleeding time. All had a normal platelet count, glass bead retention test, and platel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Czapek EE,Deykin D,Salzman E,Lian EC,Hellerstein LJ,Rosoff CB

    更新日期:1978-07-01 00:00:00

  • Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group.

    abstract::The value of a postremission treatment in acute myelogenous leukemia (AML), with alternating combinations of non-cross-resistant drugs, has been prospectively assessed. Of 515 evaluable patients, 347 (67.4%) entered into complete remission (CR), following induction treatment with daunorubicin (DNR), vincristine (VCR),...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Zittoun R,Jehn U,Fière D,Haanen C,Löwenberg B,Willemze R,Abels J,Bury J,Peetermans M,Hayat M

    更新日期:1989-03-01 00:00:00

  • Regulation of thrombosis and vascular function by protein methionine oxidation.

    abstract::Redox biology is fundamental to both normal cellular homeostasis and pathological states associated with excessive oxidative stress. Reactive oxygen species function not only as signaling molecules but also as redox regulators of protein function. In the vascular system, redox reactions help regulate key physiologic r...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2015-01-544676

    authors: Gu SX,Stevens JW,Lentz SR

    更新日期:2015-06-18 00:00:00

  • Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.

    abstract::The incidence and severity of acute graft-versus-host disease (GVHD) after allogeneic transplantation using peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor (G-CSF) appear to be no worse than those after bone marrow transplantation, despite the presence of large numbers of T cells i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pan L,Delmonte J Jr,Jalonen CK,Ferrara JL

    更新日期:1995-12-15 00:00:00

  • Relationship of a leukemia-associated antigen to the presence of lymphoblasts in the peripheral blood in children with acute lymphocytic leukemia.

    abstract::Peripheral blood samples from 57 children with newly diagnosed E-rosette-negative, surface-immunoglobulin negative acute lymphocytic leukemia (ALL) were studied for the presence of a leukemia-associated antigen (ALLA). Ficoll-Hypaque separated cells were tested using a rabbit antiserum to human null lymphoblasts and a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morgan E,Hsu CC

    更新日期:1981-05-01 00:00:00

  • Chronic lymphocytic leukemia and the Warburg effect.

    abstract::In this issue of Blood, Jitschin et al demonstrate a microenvironmental glycolytic shift in chronic lymphocytic leukemia (CLL) cells mediated by Notch-c-Myc signaling. Interfering in the Notch-c-Myc pathway and reprogramming glycolytic metabolism could contribute to overcoming drug resistance in CLL. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-04-636332

    authors: Moreno C

    更新日期:2015-05-28 00:00:00

  • GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells.

    abstract::Maintaining a steady pool of self-renewing hematopoietic stem cells (HSCs) is critical for sustained production of multiple blood lineages. Many transcription factors and molecules involved in chromatin and epigenetic modifications have been found to be critical for HSC self-renewal and differentiation; however, their...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-306563

    authors: Yu S,Cui K,Jothi R,Zhao DM,Jing X,Zhao K,Xue HH

    更新日期:2011-02-17 00:00:00

  • IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo.

    abstract::Interleukin 21 (IL-21) is a member of the common gamma-chain family of cytokines, which influence a broad spectrum of immunologic responses. A number of studies have examined the function of IL-21, but its specific role in Th1/Th2-cell differentiation and related effector responses remains to be clarified. Thus, we ge...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-021600

    authors: Fröhlich A,Marsland BJ,Sonderegger I,Kurrer M,Hodge MR,Harris NL,Kopf M

    更新日期:2007-03-01 00:00:00

  • Bone marrow delta-aminolaevulinate synthase deficiency in a female with congenital sideroblastic anemia.

    abstract::Heme biosynthesis was examined in erythroid tissue of a 4-yr-old girl with severe sideroblastic anemia since infancy, as documented by the presence of intramitochondrial deposits of iron in erythroblasts. Free red cell protoporphyrin, urinary porphyrins, and activities of erythrocyte porphobilinogen synthase, uroporph...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Buchanan GR,Bottomley SS,Nitschke R

    更新日期:1980-01-01 00:00:00

  • The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.

    abstract::Analysis of a growing number of chromosomal translocations in human tumors have shown that they frequently result in gene fusions encoding chimeric proteins. We have characterized the recurrent t(12;21)(p12;q22) translocation present in human B-lineage acute leukemias. This translocation fused two genes, tel and AML1,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Romana SP,Mauchauffé M,Le Coniat M,Chumakov I,Le Paslier D,Berger R,Bernard OA

    更新日期:1995-06-15 00:00:00

  • Bradykinin regulates the expression of kininogen binding sites on endothelial cells.

    abstract::The vasoactive compound bradykinin (BK) is liberated by proteolytic cleavage from high molecular weight kininogen (HK) and low molecular weight kininogen (LK). Expression of kininogens on cell surface receptors may affect the delivery of BK at sites of inflammation. Therefore, we investigated whether BK itself alters ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zini JM,Schmaier AH,Cines DB

    更新日期:1993-06-01 00:00:00

  • ALK+ lymphoma: clinico-pathological findings and outcome.

    abstract::A distinct pathologic entity (ALK+ lymphoma) that is characterized by expression of the anaplastic lymphoma kinase (ALK) protein has recently emerged within the heterogeneous group of CD30(+) anaplastic large-cell lymphomas. Information on clinical findings and treatment outcome of ALK+ lymphoma is still limited, and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Falini B,Pileri S,Zinzani PL,Carbone A,Zagonel V,Wolf-Peeters C,Verhoef G,Menestrina F,Todeschini G,Paulli M,Lazzarino M,Giardini R,Aiello A,Foss HD,Araujo I,Fizzotti M,Pelicci PG,Flenghi L,Martelli MF,Santucci A

    更新日期:1999-04-15 00:00:00

  • Ikaros limits basophil development by suppressing C/EBP-α expression.

    abstract::The Ikaros gene (Ikzf1) encodes a family of zinc-finger transcription factors implicated in hematopoietic cell differentiation. Here we show that Ikaros suppresses the development of basophils, which are proinflammatory cells of the myeloid lineage. In the absence of extrinsic basophil-inducing signals, Ikaros(-/-) (I...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-04-494625

    authors: Rao KN,Smuda C,Gregory GD,Min B,Brown MA

    更新日期:2013-10-10 00:00:00

  • Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.

    abstract::The use of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) following autologous marrow transplantation for lymphoid malignancies was explored in a phase I/II dose escalation study. rhGM-CSF given as a 2-hour infusion daily for 14 days was well tolerated at doses up to 240 micrograms/m2/da...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nemunaitis J,Singer JW,Buckner CD,Hill R,Storb R,Thomas ED,Appelbaum FR

    更新日期:1988-08-01 00:00:00